A clinical study of MK-3120 in people with bladder cancer (MK-3120-003)

Trial Identifier: 3120-003
Sponsor: MSD
Start Date: December 2025
Primary Completion Date: February 2029
Study Completion Date: February 2029
Condition: Bladder - Other; Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary

Trial Locations

Country Location
Austria, Wien Vienna, Wien, Austria, 1090
Belgium, Oost-Vlaanderen Gent, Oost-Vlaanderen, Belgium, 9000
Canada, QC Quebec, QC, Canada, G1J 1Z4
France, Val-de-Marne Villejuif, Val-de-Marne, France, 94800
Greece, Thessaloniki Thessaloniki, Greece, 570 01
Israel, N/A Petah Tikva, N/A, Israel, 4941492
Italy, Veneto Verona, Veneto, Italy, 37134
Netherlands, Noord-Holland Amsterdam, Noord-Holland, Netherlands, 1066 CX
Norway, Akershus Lorenskog, Akershus, Norway, 1478
Spain, Andalucia Malaga, Andalucia, Spain, 29010
Spain, Madrid, Comunidad de Madrid, Madrid, Comunidad de, Spain, 28041
Turkey, Ankara Ankara, Turkey, 06620
United States, CA Bakersfield, CA, United States, 93301
United States, SC Myrtle Beach, SC, United States, 29572